CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in STOK — Stoke Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in STOK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,280,632
+$1,046,214 QoQ
Shares Held
467,012
+6.8% QoQ
Ownership
0.724%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. STOK ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in STOK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,280,632 | 467,012 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,234,418 | 437,175 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,042,156 | 410,906 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,468,361 | 402,909 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,867,841 | 340,779 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,063,541 | 310,307 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,773,682 | 342,129 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,885,286 | 316,134 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,907,956 | 289,264 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,011,013 | 223,038 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,079,572 | 205,242 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $856,315 | 217,339 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,199,251 | 206,891 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,363,745 | 163,715 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,521,676 | 164,862 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,083,225 | 162,245 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,187,840 | 165,620 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,172,908 | 150,732 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,545,242 | 147,780 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,714,163 | 145,997 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,598,696 | 136,622 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,752,462 | 122,360 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,183,694 | 115,997 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,139,988 | 93,759 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,522,522 | 63,891 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,612,228 | 70,403 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||